Ascendis Pharma A/S T.ASND

Primary Symbol: ASND

Healthcare Biotechnology

Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).

NDAQ:ASND - Post by User

Ascendis Pharma A/S

<< Previous

Bullboard Posts

Next >>

(1)
•••

Comment by 101724on Oct 15, 2024 5:37pm

163 Views

Post# 36267153

RE:ASND: Construction decision is the second half of 2024

Who is the clown now? Per their press release of today:

Phase II is expected to be completed by late Q2 2025, and the results will be incorporated into an updated Feasibility Study. This updated study will provide the necessary data to inform a construction decision and further solidify the economic potential of the Lagoa Salgada project.

Another extension for the clown show at Extension Resources.

<< Previous

Bullboard Posts

Next >>

Hydrogen – The new trends: Plug Power, Pure Hydrogen, thyssenkrupp